• Price Momentum

    NVAX is trading near the bottom of its 52-week range and below its 200-day simple moving average.

  • Price change

    The price of NVAX shares has decreased $0.02 since the market last closed. This is a 0.23% drop.

  • Opened at $6.58.

    The stock opened $0.01 higher than its previous close.

Key terms

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $1.07B

    A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.

Key terms

Smart score

Latest NVAX news

Dec 02, 2025 6:55am ET Bank of America Securities Sticks to Their Sell Rating for Novavax (NVAX) Dec 02, 2025 6:15am ET Vaccine committee considers changes to childhood schedule, NY Times reports Dec 01, 2025 11:43am ET MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today Dec 01, 2025 11:20am ET Prasad email a headwind for vaccine manufacturers, says BofA Dec 01, 2025 9:11am ET Video: Vaccine makers slide following report of leaked memo from FDA’s Prasad Dec 01, 2025 9:05am ET Morning Movers: Synopsys leaps following Nvidia investment Dec 01, 2025 7:55am ET Prasad ties 10 children deaths to COVID vaccines in leaked memo, STAT reports Nov 26, 2025 1:25pm ET Novavax call volume above normal and directionally bullish Nov 21, 2025 2:00pm ET RFK told CDC to change website language on autism and vaccines, NYT reports Nov 20, 2025 6:15am ET CDC webpage says vaccines may cause autism, WSJ reports Nov 19, 2025 1:25pm ET Novavax call volume above normal and directionally bullish Nov 18, 2025 7:36am ET Novavax price target lowered to $6 from $7 at JPMorgan Nov 12, 2025 12:10pm ET Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), Xoma (XOMA) and Novavax (NVAX) Nov 11, 2025 8:31am ET Novavax price target lowered to $16 from $18 at B. Riley Nov 10, 2025 2:45pm ET Novavax call volume above normal and directionally bullish Nov 10, 2025 8:41am ET Novavax price target lowered to $16 from $18 at B. Riley Nov 07, 2025 8:05am ET Bank of America Securities Sticks to Their Sell Rating for Novavax (NVAX) Nov 07, 2025 7:05am ET Novavax’s Strong Financial Outlook and Strategic Partnerships Support Buy Rating Nov 06, 2025 11:43pm ET Novavax Reports Q3 2025 Earnings and Strategic Progress Nov 06, 2025 7:47pm ET Novavax’s Q3 2025 Earnings Call: Optimistic Outlook Nov 06, 2025 8:06am ET Novavax reports Q3 EPS ($1.25), consensus (92c) Nov 06, 2025 8:05am ET Novavax raises FY25 adjusted revenue view to $1.04B-$1.06B from $1B-$1.05B Nov 06, 2025 7:05am ET Options Volatility and Implied Earnings Moves Today, November 06, 2025 Nov 04, 2025 9:40am ET Novavax price target lowered to $7 from $8 at TD Cowen Nov 04, 2025 7:26am ET Novavax transfers U.S. marketing authorization for Nuvaxovid to Sanofi Nov 04, 2025 6:37am ET Novavax Transfers Nuvaxovid Rights to Sanofi Nov 03, 2025 7:35pm ET Novavax (NVAX) Gets a Hold from TD Cowen Oct 24, 2025 9:35am ET Coinbase, eBay upgraded: Wall Street’s top analyst calls Oct 24, 2025 7:50am ET Novavax initiated with an Overweight at Cantor Fitzgerald Oct 22, 2025 9:37am ET Novavax Enters Lease Agreement with AstraZeneca Oct 22, 2025 7:11am ET Novavax announces Maryland-based locations sales for $60M
Oct 16, 2024 12:45pm ET Novavax, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - NVAX Apr 20, 2022 9:03pm ET SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Novavax, Inc. Jan 11, 2022 5:26pm ET Final Deadline Today: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 11, 2022 1:02pm ET NVAX DEADLINE TODAY: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors With Losses Over $100K to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX Jan 10, 2022 5:24pm ET Deadline Tomorrow Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 10, 2022 1:00pm ET NVAX Final Deadline Tomorrow: Rosen, Trusted Investor Counsel, Encourages Novavax, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX Jan 09, 2022 11:55pm ET Thornton Law Firm Reminds Novavax (NVAX) Investors of Securities Class Action Jan 09, 2022 5:37pm ET Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. (NVAX) Investors of Filing Deadline in Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm Jan 09, 2022 10:00am ET FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Novavax, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - NVAX Jan 08, 2022 4:10pm ET TUESDAY DEADLINE: Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NVAX Jan 07, 2022 2:29pm ET Deadline Tuesday Notice: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 07, 2022 11:40am ET NVAX TUESDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Novavax, Inc. Investors With Losses Over $100K to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX Jan 06, 2022 1:36pm ET CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds NVAX Investors of Upcoming Deadline and Urges Investors with Substantial Losses to Contact the Firm Jan 06, 2022 1:25pm ET Deadline Tuesday Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 06, 2022 9:35am ET UPCOMING DEADLINE: Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NVAX Jan 05, 2022 2:00pm ET NVAX ALERT: Thornton Law Firm Reminds Novavax Investors of Securities Class Action Jan 05, 2022 1:56pm ET Tuesday Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 04, 2022 1:58pm ET 7-Day Deadline Reminder: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 03, 2022 12:38pm ET January Deadline Alert: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Jan 03, 2022 10:45am ET Thornton Law Firm Reminds Novavax, Inc. (NVAX) Investors of Securities Class Action Jan 02, 2022 10:26pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Jan 02, 2022 6:40pm ET Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Shareholders of Securities Class Action Lawsuit and Urges Investors with Significant Losses to Contact the Firm Dec 31, 2021 6:20pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX Dec 30, 2021 7:28pm ET NVAX CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Shareholders of Securities Fraud Class Action Lawsuit Dec 30, 2021 4:10pm ET NVAX DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Novavax, Inc. Investors to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX Dec 30, 2021 2:43pm ET HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Dec 29, 2021 11:15am ET NVAX ALERT: Thornton Law Firm Reminds Novavax, Inc. Investors of Securities Class Action Lawsuit Dec 27, 2021 1:26pm ET HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Dec 25, 2021 8:11pm ET Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm Dec 22, 2021 1:30pm ET NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. Dec 22, 2021 10:15am ET Thornton Law Firm Reminds Novavax, Inc. (NVAX) Investors of Securities Class Action Lawsuit Dec 20, 2021 4:00pm ET NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. Dec 20, 2021 9:30am ET HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Dec 18, 2021 6:15pm ET Rosen, A Leading Law Firm, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX Dec 16, 2021 7:15pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX Dec 15, 2021 8:10pm ET Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc. Dec 15, 2021 4:00pm ET NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. Dec 15, 2021 2:01pm ET HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Lead Plaintiff Opportunity in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys Dec 15, 2021 11:05am ET NVAX Investor Alert: Thornton Law Firm Reminds Novavax, Inc. Investors of Securities Class Action Lawsuit Dec 09, 2021 1:15pm ET NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. Dec 08, 2021 1:51pm ET HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Lead Plaintiff Opportunity in Securities Fraud Class Action Dec 07, 2021 10:58am ET NVAX Notice: Rosen, Top Ranked Global Investor Counsel, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVAX Dec 06, 2021 1:15pm ET NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. Dec 06, 2021 8:56am ET NVAX DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important January 11, 2022 Deadline Reminder for Novavax, Inc. Dec 05, 2021 2:23pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Dec 03, 2021 3:37pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Dec 03, 2021 2:04pm ET INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Dec 03, 2021 11:50am ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Dec 02, 2021 4:15pm ET NVAX Investor Alert: Shareholder Class Action Lawsuit Filed Dec 02, 2021 2:08pm ET SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Dec 01, 2021 3:45pm ET NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc. Dec 01, 2021 3:02pm ET SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Dec 01, 2021 2:54pm ET NVAX LAWSUIT: Hagens Berman, National Trial Attorneys, Encourages Novavax (NVAX) Investors with Losses to Contact Firm's Attorneys, Securities Fraud Class Action Pending Dec 01, 2021 2:16pm ET SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Dec 01, 2021 12:36pm ET NVAX Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit against of Novavax, Inc. and Encourages Investors with Substantial Losses to Contact the Firm Dec 01, 2021 6:24am ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 30, 2021 7:53pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 30, 2021 3:43pm ET NVAX Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Novavax, Inc. Shareholders Nov 30, 2021 2:10pm ET INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Nov 30, 2021 12:06pm ET SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Nov 30, 2021 6:17am ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 29, 2021 7:01pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 29, 2021 3:45pm ET NVAX Investor Alert: Class Action Lawsuit Filed Nov 29, 2021 1:04pm ET NVAX Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Novavax, Inc. Shareholders Nov 29, 2021 10:44am ET SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Nov 29, 2021 6:02am ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 28, 2021 6:59pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX Nov 28, 2021 2:38pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 27, 2021 10:15pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 27, 2021 7:22pm ET INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Alerts Novavax, Inc. (NVAX) Shareholders of Securities Fraud Class Action Lawsuit on Their Behalf Nov 26, 2021 1:44pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 26, 2021 10:25am ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 24, 2021 11:45am ET NVAX Investor Alert: Shareholder Class Action Lawsuit Filed Nov 24, 2021 10:07am ET NVAX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Notifies Novavax (NVAX) Investors of Lead Plaintiff Opportunity in Securities Fraud Class Action Nov 23, 2021 4:17pm ET NVAX DEADLINE: Novavax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Nov 22, 2021 2:29pm ET SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Nov 22, 2021 2:10pm ET NVAX Investor Alert: Shareholder Lawsuit Filed Nov 22, 2021 1:29pm ET SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Nov 22, 2021 11:15am ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 22, 2021 5:28am ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 21, 2021 6:15pm ET Important January 11, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Securities Fraud Class Action Lawsuit Nov 20, 2021 9:36pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 19, 2021 2:59pm ET SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Nov 19, 2021 2:53pm ET INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Nov 19, 2021 12:29pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 18, 2021 7:58pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 18, 2021 4:45pm ET NVAX SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm's Attorneys Now, Securities Class Action Pending Nov 18, 2021 2:41pm ET SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Novavax, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Nov 17, 2021 10:14pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 17, 2021 7:02pm ET Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc. Nov 17, 2021 3:14pm ET NOVAVAX INVESTOR ALERT: Shareholder Lawsuit Filed Nov 17, 2021 5:31am ET SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Novavax, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 11, 2022 - (NVAX) Nov 16, 2021 10:31pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 16, 2021 7:28pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 16, 2021 3:25pm ET INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages Investors with Losses to Contact the Firm Nov 15, 2021 10:40pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX Nov 15, 2021 10:07pm ET NVAX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Novavax, Inc. Nov 15, 2021 5:37pm ET NVAX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 11, 2022 in the Class Action Filed on Behalf of Novavax, Inc. Limited Shareholders Nov 15, 2021 3:41pm ET NVAX Alert: Berman Tabacco Alerts Investors with Losses in Excess of $100,000 of Deadline for Seeking Appointment as Lead Plaintiff in Novavax, Inc. Class Action Nov 15, 2021 3:35pm ET ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages Investors with Losses to Contact the Firm

NVAX Financials

1-year income & revenue

  • Total revenue: $682.16M (1Y), $70.44M (Q3)

    Total Revenue decreased 30.65% since last year and decreased 70.55% since last quarter.

  • Net income: -$187.50M (1Y), -$202.38M (Q3)

    Net Income increased 65.6% since last year and decreased 290.01% since last quarter.

  • Earnings per share: -$1.23 (1Y), -$1.25 (Q3)

    EPS increased 77.22% since last year and decreased 307.4% since last quarter.

Key terms

NVAX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NVAX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    NVAX's competitors are included in the Health Technology sector and Biotechnology group

  • Market cap: $1.07B

    A market capitalization between $300 million and $2 billion places NVAX in the small capitalization category.

Key terms